Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country 1
Phase
Study type
8 / 777 trials
PostedSponsorStudyPhaseStatus
12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting3 Nov 2026Arjil Pharmaceuticals LLCTaiwanA Study for AR100DP1 in Mild to Moderate Atopic DermatitisPhase 2Recruiting29 Oct 2026Elixiron Immunotherapeutics Inc.TaiwanA Phase 1, Open-Label, Two-Stage, Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of EI-1071 Under Fasted or Fed Conditions in Healthy VolunteersPhase 1Not Yet Recruiting27 Oct 2026T-MAXIMUM Pharmaceutical IncUnited States, TaiwanThe METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid TumorsPhase 2Not Yet Recruiting22 Oct 2026Bionime CorporationTaiwanRIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes MellitusNot applicableRecruiting22 Oct 2026Daiichi SankyoTaiwanA Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]Phase 1, Phase 2Recruiting22 Oct 2026Lumosa Therapeutics Co., Ltd.TaiwanA Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS ParticipantPhase 2Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.